RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdf
https://w3id.org/ripe/ripe-kg/work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdf
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.nmni.2025.101692Homologous and heterologous booster of COVID-19 vaccines: A systematic review and meta-analysis |
http://purl.org/spar/cito/cites |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
prism:doi |
10.1056/nejmoa2113017/suppl_file/nejmoa2113017_data-sharing.pdf |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
dcterms:title |
Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
rdf:type |
node1 |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
rdf:type |
rdfs:Resource |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
rdf:type |
owl:Thing |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
rdf:type |
prov:Entity |
ripekg:work/10.1056%2Fnejmoa2113017%2Fsuppl_file%2Fnejmoa2113017_data-sharing.pdfEfficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase |
rdf:type |
ripe:WorkWork |